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Abstract
Object In vivo magnetic resonance imaging (MRI) of
iron-labeled pancreatic islets (PIs) transplanted into the
liver is still challenging in humans. The aim of this study
was to develop and evaluate a double contrast method for
the detection of PIs labeled with superparamagnetic iron
oxide (SPIO) nanoparticles.
Materials and methods A double-echo three-dimensional
(3D) spoiled gradient echo sequence was adapted to yield a
sub-millisecond first echo time using variable echo times
and highly asymmetric Cartesian readout. Positive contrast
was achieved by conventional and relative image subtrac-
tion. Experiments for cell detection efficiency were
performed in vitro on gelatin phantoms, in vivo on a Lewis
rat and on a patient 6 months after PI transplantation.
Results It was demonstrated that the proposed method
can be used for the detection of transplanted PIs with
positive contrast in vitro and in vivo. For all experiments,
relative subtraction yielded comparable and in some cases
better contrast than conventional subtraction. For the first
time, positive contrast imaging of transplanted human PIs
was performed in vivo in patients.
Conclusion The proposed method allows 3D data acqui-
sition within a single breath-hold and yields enhanced
contrast-to-noise ratios of transplanted SPIO labeled pan-
creatic islets relative to negative contrast images, therefore
providing improved identification.
Keywords Variable echo time  3T MRI  SPIO 
Pancreatic islets  Diabetes  Positive contrast
Introduction
Superparamagnetic iron oxide nanoparticles (SPIO) induce
strong susceptibility effects that lead to a pronounced
shortening of both T2 and T2* relaxation times. Single cells
are not visible with magnetic resonance imaging (MRI),
but can be traced upon labeling with SPIO [1–3]. One of
the most successful applications of cell imaging is the
monitoring of transplanted pancreatic islets (PIs). Trans-
plantation of PIs into the liver represents a promising
alternative treatment to the well-established pancreas organ
transplantation for restoring normoglycemia in type 1
diabetes mellitus patients [4, 5]. In 2004, Jirak et al. [6]
demonstrated that SPIO-labeled pancreatic islets can be
detected as hypointense spots on T2* images following
transplantation into the rat liver. Since then, many other
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studies have been performed to monitor the fate of labeled
PIs with MRI on animal models [7–9]. Recently, Jiao et al.
[8] confirmed that ex vivo cell labeling for islet graft
imaging and monitoring with a 3T clinical scanner is fea-
sible and advantageous over 1.5T, since the susceptibility
effect of iron nanoparticles is amplified.
Noninvasive islet graft MR-imaging is successfully
applied in human livers up to 6 months after transplantation,
despite signal loss due to the clearance of the labeling from
the islets [7, 10–12]. Although the signal loss is clearly vis-
ible and can be monitored, quantitative or serial studies are
not easily performed [10, 13, 14]. Typically, the iron-labeled
islets appear as hypointense spots on conventional T2 or T2*
MRI, but susceptibility artifacts, such as air-tissue interfaces,
or other effects like calcification or flow-related signal loss,
could also yield negative contrast, and thus reliable identi-
fication of false positives can become an issue. In addition,
using the signal void as a means of detection can be hindered
by severe partial volume effects [14]. As a result, positive
contrast MR techniques [15–18] such as double echo ultra-
short echo time (UTE) methods were proposed to prevent
such false positive results [19]. Recently, the feasibility of
quantitative imaging and automatic thresholding of islets
labeled with iron oxides with a positive contrast UTE-based
MRI method was shown [19–21]. UTE allows successful
islet detection in rats, but image acquisition requires respi-
ratory triggering, which in this case was achieved with a
specialized respiratory pad system [19]. In humans, how-
ever, UTE with respiratory triggering for abdominal imaging
has not yet been applied.
In UTE techniques, it is common to use a subtraction
image (i.e., subtracting a later echo from the UTE image) in
order to yield positive contrast and increase the conspicuity
in the detection of labeled islets [14, 21]. This kind of posi-
tive contrast serves in reducing false positives, but in prin-
ciple, the two images could also be used for weighted
subtraction in order to yield a weighted positive contrast. In
2013, Martirosian et al. [22] proposed a relative subtraction
method to enhance the positive contrast in a modified DESS
sequence.
Contemporary imaging protocols used in standard clinical
practice for the follow-up of the islet grafts in patients
include balanced steady-state free precession (bSSFP) and
spoiled gradient echo (SPGR) sequences [11]. Gradient echo
methods provide good anatomic liver images, but usually
only a few two-dimensional (2D) slices can be acquired in a
breath-hold. The goal of this study was to develop an MRI
technique for 3T scanners that could monitor the fate of
transplanted labeled islets in patients. As a result, we mod-
ified a contemporary sequence that was already being used in
the clinic for the screening of diabetic patients after trans-
plantation. Instead of the typically implemented 2D proto-
col, we used a three-dimensional (3D) protocol to achieve
larger volume coverage with improved signal-to-noise ratio.
A Cartesian sub-millisecond echo time SPGR 3D sequence
was used and optimized for the in vivo visualization of SPIO-
labeled PIs in the liver, in order to yield positive contrast
images from patient single-breath–hold imaging. Visuali-
zation of pancreatic islets was explored with conventional
and weighted subtraction images. The variable echo time
scheme in combination with a highly asymmetric readout, as
demonstrated in a previous study [23], allowed an important
reduction of the echo time down to 0.65 ms, while simulta-
neously achieving a sufficiently high resolution (i.e.,
1.3 9 1.3 mm2 in-plane) for in vivo scanning of humans.
Materials and methods
Animal experiments
All protocols were approved by the Ethics Committee of
the Institute for Clinical and Experimental Medicine and
the Committee for Animal Care of the Second Faculty of
Medicine of Charles University. The experiments were
carried out in accordance with the European Communi-
ties Council Directive of 24 November 1986 (86/609/
EEC).
Islet isolation, labeling and transplantation for animal
experiments
Male Lewis rats (Anlab, Czech Republic) were used as islet
donors, as well as recipients for in vivo experiments. The
pancreases of donor rats were distended by collagenase
(1 mg/ml; Sevapharma, Czech Republic) and incubated at
37 C in a water bath for 20 min. The islets were separated
from exocrine tissue by centrifugation in a discontinuous
Ficoll gradient (Sigma, USA). Purified islets were culti-
vated in CMRL-1066 medium (PANBiotech GmbH, Ger-
many) supplemented with 10 % fetal calf serum, 1 %
penicillin/streptomycin/L-glutamine and 1 % HEPES (all
reagents from Sigma, USA) in a humidified CO2 incubator
at 37 C and 5 % CO2 atmosphere. For islet labeling, the
MR contrast agent ferucarbotran (RESOVIST; Schering
AG, Germany) was used (5 ll/ml) and pancreatic islets
were cultured for 24 h. Before transplantation, labeled
islets were washed three times in Hanks Balanced Saline
Solution (Sigma, USA). A total of 1,500 hand-picked
labeled islets were transplanted under general anesthesia
into the portal veins of recipients.
Human islet isolation, labeling and transplantation
After purification and washing, the islets were transferred
into the culture medium CMRL-1066 (PAN Biotech
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GmbH, Germany), which was modified and supplemented
according to the Miami Center [23]. Before culture, MRI
contrast agent ferucarbotran 5 lL/mL (RESOVIST;
Schering AG, Germany) was added. The islets were in
culture for 24 h, and before transplantation, the labeled
islets were washed again in the culture medium to remove
the free ferucarbotran. Then 320,000 islet equivalents were
infused in local anesthesia percutaneously under radiologic
control into the portal vein within approximately 60 min.
MRI imaging
Sub-millisecond SPGR sequence
A double contrast selective 3D SPGR sequence with a
variable first echo time (TE) in combination with a highly
asymmetric readout was used [23]. Here, the TE of the first
echo varies dynamically across k-space, enabling a mini-
mum effective echo time, while highly asymmetric sam-
pling allows for even further reduction of the echo time.
Both echoes were acquired after each single excitation.
This provided sub-millisecond TE for the first echo, as a
key for positive contrast imaging and monitoring of islets
labeled with SPIO. Furthermore, islet detection is facili-
tated within a stack of contiguous slices that is a 3D
acquisition. A 3D sequence enables easier acquisition of
multiple contiguous slices (i.e., in respect to 2D) to facil-
itate the islet detection. A special projection onto convex
sets algorithm [24] provided by the manufacturer was used
to compensate for the asymmetric data sampling.
Positive contrast and relative subtraction images
In order to yield positive contrast, a later echo was sub-
tracted from the sub-millisecond first echo, and the image
difference was reconstructed online [25]. Apart from the
subtraction images, weighted subtraction images were also
produced in post-processing. As has been demonstrated by
Martirosian et al. [22], by adding a weighting factor, the
positive contrast can appear significantly higher. Relative
subtraction images were reconstructed offline with Matlab
7.0 (The Mathworks, Inc., MA, USA, R2008b) according
to the following formula:
STE1  STE2ð Þ= STE1 þ STE2ð Þ ð1Þ
where STE1 is the signal from the first short echo and
STE2 the signal from the later echo.
Contrast analysis
In order to yield a quantitative estimation of the quality of
the contrast, relative contrast-to-noise ratios (CNR) were
calculated. For the evaluation of the islet-related signal loss
in the first and second echo images, contrast ratios were
calculated according to the following equation:
CNRA =
SNRBG  SNRROI
SNRBG
ð2Þ
where SNRROI is the signal-to-noise ratio (i.e., mean value
of the signal divided by the standard deviation of the noise)
of the labeled islets, and SNRBG is the SNR of the signal in
a ROI in the islet surroundings (i.e., the liver tissue in the
animal and human scans). For the evaluation of the positive
islet contrast in the image difference and relative
subtraction image, contrast ratios were calculated from:
CNRB =
SNRROI  SNRBG
SNRROI
ð3Þ
Phantom imaging
Pancreatic rat and human islets were labeled with Resovist
(Schering AG, Germany) for 1 day, and were then inserted
into a cylindrical gel phantom in order to test the sequence
performance with respect to islet separation and detection.
Human and rat islets were separated in two different small
tubes and then placed in a larger cylindrical phantom filled
with gel. Labeled islets were placed in the surrounding gel
as well. Phantom scans were performed in a whole body 3T
clinical system (Verio, Siemens Erlangen). For protocol
details, see Table 1.
Animal MR imaging
The Lewis rat was scanned in a whole body clinical system
(3T Tim Trio, Siemens Medical Solutions, Erlangen,
Germany) with a dedicated 8-channel transmit/receive
animal coil (Rapid Biomedical, Germany). For protocol
details, see Table 1. For reference, high-resolution
(0.23 mm in-plane) standard SPGR images (TE = 3.7 ms)
were acquired using a 4.7T Bruker Biospec Spectrometer
equipped with a resonator coil (Bruker, Germany). During
the examination, anesthesia was induced and continued by
spontaneous breathing of 3 % and 1–2 % isoflurane in the
surrounding air, at 3T and 4.7T respectively.
Human imaging
The protocol was tested and evaluated on three healthy
volunteers, and subsequently a patient, who was a member
of the cohort of patients studied under the ENCITE project
[www.encite.org], was scanned 6 months after transplan-
tation [9] on a 3T whole body clinical scanner (Tim Trio,
Siemens Medical Solutions, Erlangen, Germany). The study
was approved by the Ethics Committee of the Institute for
Clinical and Experimental Medicine. All participants of the
project were informed about the nature and potential risks
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of the study and signed their informed consent. The subjects
were examined in supine position with a 6-channel body
phased-array coil placed on the upper abdomen.
Besides the 3D variable echo time (vTE) SPGR scan (see
Table 1), the examination included a typical clinical proto-
col setting, comprising an axial and coronal HASTE for
anatomical reference and a balanced SSFP sequence, as well
as a current 2D SPGR protocol for pancreatic islet detection
(cf [11]; for comparison of protocol parameters, see
Table 1), and the whole examination did not exceed 1 h. The
additional positive contrast scans increased the total scan
protocol by three breath-hold scans of 19 s each (i.e., the
acquisition was repeated to scan different parts of the liver); a
3D transverse data set with 50 % slice oversampling was
acquired in a single breath-hold at end-expiration mode.
GRAPPA acceleration of a factor of 2 and Partial Fourier 6/8
in slice direction was used to reduce the scan time. The flip
angle was adjusted in order to yield optimum signal from the
liver so that the long T2 species suppression would be opti-
mal. For protocol details, see Table 1.
Results
Phantom scan
The sub-millisecond short echo time image (see Fig. 1a)
exhibited homogenous signal, and almost no hypointensi-
ties were present. In the second echo (see Fig. 1b), islets
appeared as dark areas of smaller or bigger extent, as a
result of the different amount of contrast agent. In the
image difference (see Fig. 1c) and in the relative image
difference (see Fig. 1d), islets appeared as hyperintense
areas that could easily be distinguished from the back-
ground. The contrast of the islets looks similar in the image
difference and in the relative image difference. Both ima-
ges yielded better CNR in comparison to the late echo,
while the CNRs with both positive contrast methods were
almost identical (see Table 2). The smallest visible
hyperintensities could be attributed to single islets, which
was verified by visual observation.
Animal scan
In the animal subject, the liver exhibited completely
homogenous signal in the sub-millisecond first echo image
acquired with the proposed method (see Fig. 2ai), while the
labeled islets appeared as dark spots in the second echo (see
Fig. 2aii). The short echo image provided enough signal in
the proximity of the islets for the reconstruction of a positive
contrast image (see Fig. 2aiii), from which the islets
appeared hyperintense and could easily be identified. On the
relative subtraction images (see Fig. 2aiv), equal amounts of
hyperintense spots were detected, while the contrast-to-noise
was improved (see Table 2). As can also be observed in the
zoomed images (see Fig. 2b), the relative-subtraction ima-
ges yielded better contrast for the islets.
The location and presence of islets was confirmed by
comparison to the high-resolution images from the experi-
mental 4.7T scanner. The same position was confirmed by
looking at bigger anatomical structures. On Fig. 2c, a high-
resolution image from the experimental scanner is presented,
which corresponds to the same position as the vTE SPGR
images (see Fig. 2a). By comparison of the respective ima-
ges, it was possible to confirm that the contrast observed on
the positive contrast images was indeed due to the presence
of labeled islets.
Patient scan
Transplanted pancreatic islets could be identified in
T2-weighted and in positive contrast images in only a few
positions (i.e., positive contrast images were acquired only
in selected positions). In patient positive contrast images,
Table 1 Protocol parameters used at 3T
3T MRI Phantom Rat scans Patient scan
3D sub-ms SPGR 2D axial SPGR bSSFP (three phase cycles)
In-plane resolution (mm) 1.25 0.74 1.33 0.8 1.3
FOV (mm) 400 9 275 380 9 261 340 9 244 400 9 262 400 9 250
Slices/slice thickness (mm) 10/2.5 16/1.25 8/2.5 2/2.5 12/2.5
Bandwidth (Hz/pixel) 401 515 455 315 745
TE1 (ms)/RO asymmetry (%)
a 0.61/9 0.8/15.6 0.65/19.5 5/100 2/100
TE2 (ms)/RO asymmetry (%) 6/100 6/100 6/100 - -
TR (ms)/Flip angle () 15/8 15/8 10/8 20/30 4/40-60
Acquisition time 23.11 s 8.28 min 19 s 18 s 20 s
Number of signal averages 1 4 2 4 1
Slice oversampling (%) 60 50 50 – –
a RO asymmetry (Readout asymmetry): percentage of readout sampling before the center of k-space
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islets were detected on two different non-adjacent slices
(see Fig. 3 left and right). They could be identified as
regions without any hypointensities present in the sub-
millisecond first echo acquired at 0.65 ms (see Fig. 3a) and
hypointense regions on the second echo (see Fig. 3b). On
the positive contrast image (i.e., the image difference),
distributed hyperintensities (see Fig. 3c) were visible in the
close vicinity of the islets. On the relative subtraction
images, islets were also identified in both positions (see
Fig. 3d). The relative subtraction images offer better
background suppression, and therefore better contrast-to-
noise (see Table 2). In one of the slices (see Fig. 3c right),
positive contrast imaging revealed the possible presence of
an islet not discernible on the later echo image. From its
overall characteristics of appearance, i.e. its location, signal
amplitude and shape, the hyperintensity most likely reflects
the presence of a labeled pancreatic islet. The fact that with
the positive contrast scans islets were identified only in two
locations could be attributed to the fact that the patient was
scanned 6 months after transplantation where the majority
of the iron was cleared out from islets or islets were already
lost [6, 11].
Fig. 1 Cylindrical gel phantom
with rat and islets. The circular
forms visible in the short a and
long, b echo image are smaller
gel containers to separate the rat
from the human islets. The
images were acquired at 3T field
strength: a sub-millisecond first
echo image acquired at 0.61 ms,
b second echo image acquired at
6 ms, c positive contrast image
(subtraction of the second echo
from the first echo), where the
islets appear as hyperintensities,
d relative subtraction image.
The ROIs for which the CNRs
were calculated are indicated on
sub-Fig. b
Table 2 CNRs for selected ROIs from Figs. 1, 2 and 3
CNRA CNRB
TE1 TE2 Pos. Contrast Rel. Subtraction
Phantom ROI1–10 0.01 ± 0.03 0.11 ± 0.04 0.87 ± 0.08 0.88 ± 0.08
Rat ROI1–5 0.05 ± 0.03 0.27 ± 0.05 0.26 ± 0.05 0.44 ± 0.10
Patient ROI1 0.00 0.15 0.37 0.43
ROI2 0.03 0.31 0.64 0.71
The ROIs are indicated on the figures of the relevant experiments. The standard deviation is calculated out of the mean value of all ten or five
ROIs for the phantom and rat images, respectively. Positive contrast images have higher contrast than the second echo images, and the relative
subtraction images have comparable or higher ratios in comparison to positive contrast images
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Discussion
In this study, the development of a sequence that provides
sub-millisecond echo times similar to UTE techniques
allowed positive contrast imaging of species with very
short T2*. As a basis for the development of the sequence,
a 3D SPGR template was used, since in addition to high
contrast anatomical images, it offers larger volume cover-
age, and is suitable for application in a breath-hold (i.e., we
suppose there will be a benefit for patients who have
trouble holding their breath, especially in end-expiration
mode). The sequence demonstrated high sensitivity, as
even single islets could be visualized in vitro with positive
contrast images. Labeled PIs were also identified positively
in the rat, as well as in the patient scans.
In addition, the fact that the sequence is fast and flexible
could also offer the possibility of adding special
preparation schemes for fat suppression or other utilities.
This could be especially useful in the case of obese patients
or patients with fibrotic liver.
The technique has shown low sensitivity to shimming
issues. During the experiment, only the standard product
pre-scan 3D shimming procedure was used. As we can see
from Fig. 1, this can be an issue at the edges of phantom,
but nevertheless, we see on Fig. 3 that the image quality on
the liver does not suffer from any shimming issues.
The background level has lower intensity in the positive
contrast images, but is more suppressed in the relative
subtraction ones. In this case, the patient was scanned
6 months after transplantation, and the labeling effect is
not so strong any more. As a result, thresholding would be
challenging, but in the case of patients scanned in a shorter
time after the transplantation, it would be probably
feasible.
Fig. 2 MR images from a rat that has undergone transplantation of
PIs: a axial sample images from 3D variable TE SPGR images from a
clinical 3T MR scanner: (i) sub-millisecond first echo image
(TE = 0.8 ms), (ii) second echo image (TE = 6.75 ms), (iii) image
difference, (iv) relative subtraction image, b details from all four
images of sub-Fig. 2a, where the labeled islets are more clearly
visible (on sub-Fig. 2biv, the ROIs that were used for CNR
calculations are indicated) c high-resolution (i.e. 0.23 mm) axial
SPGR sample image (from a 2D multi-slice data set) acquired on an
experimental 4.7T animal scanner
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Currently, due to a pause in production of Resovist for
human use, further research related to SPIO labeled islets on
humans must be delayed. There is active research towards
new agents that investigate the use of different particles such
as magnetoliposomes [26]. Methods using particles with an
iron concentration comparable to the currently used or higher
could profit from the proposed method.
A significant finding of this study was the confirmation
of the clearance of the area representing transplanted islets
in human liver over time by a different imaging approach.
It is another part of the mosaic where we try to image
transplanted pancreatic islets, because it confirms the
results obtained from previously used animal models and
human studies [11]. In addition, the fact that islets could be
detected with a double contrast approach in breath-hold
scans even after 6 months after transplantation is a prom-
ising result for future applications.
The two different positive contrast methods exhibited
better contrast than the late echo images. The relative sub-
traction images yielded comparable, or in some cases, better
contrast than the simple subtraction images. In the animal
experiment, CNR for islet detection is, in contrast to Crowe
et al. [19], comparable in the late echo and the positive
contrast image, but lower in the relative contrast image.
Fig. 3 MR images (1.3 9 1.3 9 2.5 mm3, acquisition time 19 s)
acquired at two different slice positions (left and right) at 3T with a
variable TE 3D SPGR sequences from a patient, who had undergone
transplantation of labeled pancreatic islets: a sub-millisecond first
echo acquired at 0.65 ms, b second echo at 6 ms, c difference image,
d relative subtraction image. The ROIs of the islets that were used for
CNR calculations are indicated on Fig. 3b
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We showed that the use of the proposed 3D vTE SPGR
sequence is transferable to the situation in patients with
transplanted pancreatic islets, and we believe this approach
might be extended to any kind of iron labeled cells. Finally,
the most important result from the current study is that
achieving sub-millisecond echo time with the proposed 3D
short echo time sequence, provides high CNR, good anat-
omy information and sensitivity to SPIO labeled cells
during a breath-hold of a patient.
Conclusion
The proposed 3D vTE SPGR sequence is sensitive to iron
labeled single islets in vitro, and can be used to identify SPIO
labeled islets in the liver. The achievement of sub-millisec-
ond echo time while preserving high image contrast allowed
successful reconstruction of positive contrast images and
relative subtraction images. Islets were identified positively
in positive contrast images in an animal in vivo, as well as in a
patient. To our knowledge these are the first patient results of
positive contrast liver MRI for detecting pancreatic islets.
This sequence could improve the segmentation accuracy in
unclear cases of islet detection, and relative subtraction
could offer important information for threshold identifica-
tion with increased contrast-to-noise.
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